284492-22-4 Usage
Uses
Used in Pharmaceutical Synthesis:
3-N-BOC-3-(3-Nitrophenyl)propionic acid is used as a reagent in the pharmaceutical industry for the synthesis of peptides and pharmaceuticals. Its role in protecting amino acids during peptide coupling reactions is crucial for the successful formation of desired peptide bonds, ensuring the correct sequence and structure of the final product.
Used in Organic Synthesis:
In the field of organic synthesis, 3-N-BOC-3-(3-Nitrophenyl)propionic acid serves as a versatile reagent for the protection of functional groups, particularly amino groups. This protection allows chemists to carry out reactions selectively, preventing unwanted side reactions and facilitating the synthesis of complex organic molecules.
Used in Research and Development:
3-N-BOC-3-(3-Nitrophenyl)propionic acid is also utilized in research and development settings, where it can be employed to study the properties and reactivity of nitrophenylpropanoic acid derivatives. Its use in this context contributes to the advancement of knowledge in organic chemistry and the development of new synthetic methods and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 284492-22-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,4,4,9 and 2 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 284492-22:
(8*2)+(7*8)+(6*4)+(5*4)+(4*9)+(3*2)+(2*2)+(1*2)=164
164 % 10 = 4
So 284492-22-4 is a valid CAS Registry Number.
InChI:InChI=1/C14H18N2O6/c1-14(2,3)22-13(19)15-11(8-12(17)18)9-5-4-6-10(7-9)16(20)21/h4-7,11H,8H2,1-3H3,(H,15,19)(H,17,18)
284492-22-4Relevant academic research and scientific papers
CYTOSTATIC CONJUGATES WITH INTEGRIN LIGANDS
-
Page/Page column 8; 19, (2020/06/01)
The present invention relates to novel pharmaceutical compounds comprising of an αvβ3 integrin antagonist, a linking unit comprising of L-Val – L-Pro – L-Asp cleavable by elastase, a polyethyleneglycol (PEG) spacer and a cytotoxic element, to processes for preparation thereof, to the use thereof for treating, preventing or managing diseases and conditions including hyperproliferative disorders such as cancer in humans and other mammals.
